543635 and PPLPHARMA. Related Headlines

Go Back

Aug 4, 2026 04:51AM Piramal Pharma Solutions Expands Peptide API Facility with Advanced Spray Drying Suite
Jul 29, 2026 03:27PM Piramal Pharma Limited Announces Results for Q1 FY27
Jul 7, 2026 08:36AM Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
Jun 22, 2026 04:46AM Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits
May 18, 2026 09:00AM Piramal Pharma Solutions Announces Partnership with Botanix to Support Drug Substance Development
May 13, 2026 10:37AM Piramal Pharma Solutions Unveils State-of-the-Art Payload-Linker Suite at its Riverview, Michigan Facility
Apr 16, 2026 08:00AM Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing
Mar 16, 2026 05:27AM Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch
Feb 2, 2026 11:00AM Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities
Jan 29, 2026 12:35AM Piramal Pharma Limited Announces Results for Q3 and 9M FY26
Dec 15, 2025 12:49AM Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score
Nov 19, 2025 02:41AM Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates
Nov 5, 2025 12:57PM Piramal Pharma Limited Announces Results for Q2 and H1 FY26
Oct 30, 2025 01:15AM Piramal Pharma Solutions Formalizes Partnership with IntoCell, Expanding its Payload-Linker Platform and Bioconjugate Capabilities

543635 and PPLPHARMA. Related Press Releases

Go Back

Aug 4, 2026 04:51AM Piramal Pharma Solutions Expands Peptide API Facility with Advanced Spray Drying Suite
Jul 29, 2026 03:27PM Piramal Pharma Limited Announces Results for Q1 FY27
Jul 7, 2026 08:36AM Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
Jun 22, 2026 04:46AM Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits
May 18, 2026 09:00AM Piramal Pharma Solutions Announces Partnership with Botanix to Support Drug Substance Development
May 13, 2026 10:37AM Piramal Pharma Solutions Unveils State-of-the-Art Payload-Linker Suite at its Riverview, Michigan Facility
Apr 16, 2026 08:00AM Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing
Mar 16, 2026 05:27AM Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch
Feb 2, 2026 11:00AM Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities
Jan 29, 2026 12:35AM Piramal Pharma Limited Announces Results for Q3 and 9M FY26
Dec 15, 2025 12:49AM Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score
Nov 19, 2025 02:41AM Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates
Nov 5, 2025 12:57PM Piramal Pharma Limited Announces Results for Q2 and H1 FY26
Oct 30, 2025 01:15AM Piramal Pharma Solutions Formalizes Partnership with IntoCell, Expanding its Payload-Linker Platform and Bioconjugate Capabilities

543635 and PPLPHARMA. Related SEC Filings

Go Back